Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 140 publications
Enhanced BCMA Antigen Density Increases Trogocytosis and Attenuates CAR T cell Function.
Journal: bioRxiv : the preprint server for biology
Published: July 29, 2026
Coordinated expansion of CD163⁺ monocytes and immature CD177⁺ neutrophils marks severe neurotoxicity after CD19 CAR T cell therapy.
Journal: bioRxiv : the preprint server for biology
Published: July 17, 2026
Erratum: Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts.
Journal: Molecular therapy. Oncology
Published: February 09, 2026
A novel dose-dense strategy for CD19-directed CAR T-cell therapy is associated with durable responses without increased toxicity in patients with B-cell non-Hodgkin lymphoma.
Journal: Haematologica
Published: December 19, 2025
Quantifying HLA transcripts by genotype in chimeric mixtures at single-cell resolution.
Journal: bioRxiv : the preprint server for biology
Published: September 26, 2025
Balancing the efficacy and safety of chimeric antigen receptor T-cell therapy by affinity combination.
Journal: Nature communications
Published: June 11, 2025
Impact of Gamma-Secretase Inhibition on Outcomes Following BCMA CAR-T Therapy in Multiple Myeloma: A Comparison of Two Phase 1 Trials.
Journal: Transplantation and cellular therapy
Published: May 18, 2025
CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target.
Journal: The Journal of clinical investigation
Published: August 15, 2024
Phase I Study of ROR1-Specific CAR-T Cells in Advanced Hematopoietic and Epithelial Malignancies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 11, 2024
Last Updated: 09/26/2026